Photo credit: https://hivglasgow.org/ At this year’s HIV Glasgow Conference, Dr Anchalee Avihingsanon presented the results of…
Category: News
Delegation from The United States Department of Health and Human Services Visited HIV-NAT, Thai Red Cross AIDS and Infectious Diseases Research Centre
The National Health Institute (NIH) of the United States has awarded the Thailand HIV/AIDS and Infectious…
Delegation from The United States Department of Health and Human Services Visited Chulalongkorn Hospital, Thai Red Cross Society
From https://chulalongkornhospital.go.th/kcmh/ On August 25, 2022, Ms.Andrea Palm, the Deputy Secretary of Health and Human Services…
Dr. Anchalee Avihingsanon presented research at the 24th International AIDS Conference (AIDS 2022) in Montreal, Canada
From aidsmap.com At the 24th International AIDS Conference (AIDS 2022) in Montreal, Canada, Dr Anchalee Avhingsanon reported the…
What people living with HIV need to know about HIV and COVID-19
COVID-19 is a serious disease and all people living with HIV should take all recommended preventive…
UNAIDS Board adopts new global AIDS strategy which paves the way to end AIDS by 2030
From: UNAIDS The new Global AIDS Strategy 2021–2026, End Inequalities, End AIDS, is a bold approach…
In Memoriam: Professor Dr Charles Boucher
From: Erasmus MC In the early morning of February 26, Prof Dr Charles Boucher (63) passed…
END INEQUALITIES – Zero Discrimination Day – 1 March 2021
From: UNAIDS On Zero Discrimination Day this year (download brochure), UNAIDS is highlighting the urgent need…
THAI-CTU was awarded
The re-competition for the Clinical Trial Unit (CTU) grant by the National Institutes of Health (NIH)…
11th D2EFT study newsletter
D2EFT: Dolutegravir and Darunavir Evaluation in Adults Failing Therapy Update from a study site: HIV-NAT Thai…
UNAIDS welcomes new tool for HIV prevention for gay men and other men who have sex with men and transgender women
UNAIDS warmly welcomes the announcement that the long-acting injectable cabotegravir is safe and effective in preventing…
COVID-19: What people with HIV should know
Although the risk of serious illness from COVID-19 for people with HIV is not known, people…
Congratulations to our August 2019 PhD graduates
The Kirby Institute would like to congratulate our PhD graduates, Dr Steve Badman and Dr Sasiwimol…
PERSPECTIVES: Are integrase inhibitors the solution to HIV drug resistance in the Asia-Pacific region?
We asked four regional clinicians, researchers, and policy makers to share their reflections on whether integrase…
